ROCKET LAB CORP

Rocket Lab (RKLB) outpaces SpaceX with a 4 % rise, driven by steady launch growth, analyst upgrades and small‑cap ETF exposure—boosting long‑term aerospace potential.

Rocket Lab’s $8 B Iridium takeover turns a launch‑maker into a fully integrated satellite powerhouse, adding steady broadband revenue and global reach.

Rocket Lab’s 10th consecutive launch and new NASA contracts boost investor confidence, spiking shares while highlighting operational excellence and growth potential.

Rocket Lab’s 8% Nasdaq‑100 slide shows a “sell‑the‑news” pause: strong revenue growth, yet a hefty negative P/E and high cap‑ex keep investors on edge.

Rocket Lab shares soar 8% after $90M Space Force contract, strong Q1 revenue, and SpaceX IPO buzz—discover how the deal fuels a 94% year‑to‑date rally and future growth.

Rocket Lab’s 430 % rally, analyst‑boosted price targets, and 52‑week low raise red flags; investors must weigh the company’s negative P/E and sector volatility before chasing space‑flight hype.

Rocket Lab’s Q1 2026 results reveal a dramatic revenue lift to $200 M, a $2.2 B backlog, and positive EBITDA, marking a shift from high‑risk startup to a mature, growth‑oriented space launch provider poised for larger defense and commercial contract…

Rocket Lab’s booming space business fuels investor interest, thanks to record government contracts, the new Neutron rocket and a focus on reusable tech.

Rocket Lab’s record revenue growth clashes with launch delays, over‑expansion, and a steep negative P/E, leaving investors wary of a shaky market outlook.

Rocket Lab’s Q4 2025 earnings loom: investors eye a potential surge amid a booming commercial launch market, but testing setbacks and a negative P/E flag risk‑taker caution.